Cargando…
SIRT1 overexpression protects non-small cell lung cancer cells against osteopontin-induced epithelial-mesenchymal transition by suppressing NF-κB signaling
Osteopontin (OPN) is a promoter for tumor progression. It has been reported to promote non-small cell lung cancer (NSCLC) progression via the activation of nuclear factor-κB (NF-κB) signaling. As the increased acetylation of NF-κB p65 is linked to NF-κB activation, the regulation of NF-κB p65 acetyl...
Autores principales: | Li, Xuejiao, Jiang, Zhongxiu, Li, Xiangmin, Zhang, Xiaoye |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5841350/ https://www.ncbi.nlm.nih.gov/pubmed/29535539 http://dx.doi.org/10.2147/OTT.S137146 |
Ejemplares similares
-
Osteopontin—A Master Regulator of Epithelial-Mesenchymal Transition
por: Kothari, Anai N., et al.
Publicado: (2016) -
Overexpression of SIRT1 promotes metastasis through epithelial-mesenchymal transition in hepatocellular carcinoma
por: Hao, Chong, et al.
Publicado: (2014) -
Regulatory roles of osteopontin in human lung cancer cell epithelial‐to‐mesenchymal transitions and responses
por: Shi, Lin, et al.
Publicado: (2021) -
Osteopontin Splicing Isoforms Contribute to Endometriotic Proliferation, Migration, and Epithelial-Mesenchymal Transition in Endometrial Epithelial Cells
por: Ho, Nguyen-Tuong, et al.
Publicado: (2022) -
Overexpression of Livin promotes migration and invasion of colorectal cancer cells by induction of epithelial–mesenchymal transition via NF-κB activation
por: Ge, Yang, et al.
Publicado: (2016)